Literature DB >> 25225675

How the current West African Ebola virus disease epidemic is altering views on the need for vaccines and is galvanizing a global effort to field-test leading candidate vaccines.

Myron M Levine1, Milagritos Tapia1, Adrian V Hill2, Samba O Sow3.   

Abstract

Entities:  

Keywords:  Ebola virus; outbreak control; reactive immunization; vaccines

Mesh：

Substances：

Year:  2014        PMID： 25225675     DOI： 10.1093/infdis/jiu513

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

Review 1.  Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

Authors:  Ana Cláudia Coelho; Juan García Díez
Journal:  Front Bioeng Biotechnol       Date:  2015-04-28

2.  Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats.

Authors:  Georgina Drury; Siobhan Jolliffe; Tarit K Mukhopadhyay
Journal:  Vaccine       Date:  2019-03-22       Impact factor: 3.641

3.  Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.

Authors:  Milagritos D Tapia; Samba O Sow; Kirsten E Lyke; Fadima Cheick Haidara; Fatoumata Diallo; Moussa Doumbia; Awa Traore; Flanon Coulibaly; Mamoudou Kodio; Uma Onwuchekwa; Marcelo B Sztein; Rezwanul Wahid; James D Campbell; Marie-Paule Kieny; Vasee Moorthy; Egeruan B Imoukhuede; Tommy Rampling; Francois Roman; Iris De Ryck; Abbie R Bellamy; Len Dally; Olivier Tshiani Mbaya; Aurélie Ploquin; Yan Zhou; Daphne A Stanley; Robert Bailer; Richard A Koup; Mario Roederer; Julie Ledgerwood; Adrian V S Hill; W Ripley Ballou; Nancy Sullivan; Barney Graham; Myron M Levine
Journal:  Lancet Infect Dis       Date:  2015-11-04       Impact factor: 25.071

4.  A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits.

Authors:  Gabriela M Escalante; Joslyn Foley; Lorraine Z Mutsvunguma; Esther Rodriguez; David H Mulama; Murali Muniraju; Peng Ye; Anne K Barasa; Javier Gordon Ogembo
Journal:  Vaccines (Basel)       Date:  2020-04-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.